GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC4XD.L Share News (C4XD)

  • There is currently no data for C4XD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: C4X Shares Double On Indivior Licensing Deal

Thu, 29th Mar 2018 10:28

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Wm Morrison Supermarkets, up 2.7%. Bernstein raised the grocer to Outperform from Market Perform.Mediclinic International, up 1.8%. The private healthcare operator said chief executive designate, Ronnie van der Merwe, will begin his new role as CEO in June, whilst it also announced the departure of two non-executive directors, Nandi Mandela and Robert Leu.----------FTSE 100 - LOSERS----------Compass, down 3.1%. The caterer was lower after a weak set of half-year results from French peer Sodexo. Organic revenue growth of 1.7% for the first half of its financial year and and underlying operating margin of 6.1% were both below expectations, the company said. Sodexo said it expects revenue decline in North America and a slower than anticipated conversion of pipeline opportunities into new contract wins will weigh on top line growth and margins in the second half. "Investors clearly worry that Sodexo's pain is representative of the catering market as a whole, therefore Compass is at risk," said AJ Bell investment director Russ Mould.Shire, down 2.0%. The drugmaker was giving up some of Wednesday's gains, when it closed up 14% on news Japanese pharmaceutical firm Takeda Pharmaceutical confirmed it is "considering making an approach" for London-listed firm.----------FTSE 250 - WINNERS----------IP Group, up 8.6%. The intellectual property swung to a GBP53.4 million pretax profit for 2017 from a GBP14.8 million loss the year prior. IP Group reported an increase in the fair value of its portfolio to GBP1.1 billion from GBP614.0 million in 2016. It had assets of GBP1.5 billion as at the end of December, up from GBP768.7 million assets it had the year before. "Overall, the underlying performance of the group's enlarged portfolio was strong with a number of key milestones attained. The integration of Touchstone Innovations with IP Group is proceeding to plan and we are confident for the year ahead and beyond," IP Chief Executive Officer Alan Aubrey said.----------FTSE 250 - LOSERS----------Provident Financial, down 2.0%. The subprime lender was cut to Sell from Hold by Berenberg.----------OTHER MAIN MARKET AND AIM - WINNERS----------C4X Discovery, shares more than doubling to 115.00p from Wednesday's close of 56.50p. FTSE 250-listed Indivior said its subsidiary Indivior UK and C4X Discovery have entered into a license agreement, whereby Indivior UK has obtained "exclusive global rights" to develop and commercialize C4X's oral orexin-1 receptor antagonist program. Under the terms of the agreement, Indivior UK will make an upfront payment to C4X of USD10 million with potential milestone payments to C4X that could total USD284 million "over time", if all development, regulatory and commercial goals are achieved. Indivior was down 0.1%.CMC Markets, up 8.6%. The online trading platform said its "strong" performance in the year to date was maintained in its final quarter ending Saturday as its Australian partnership continues to progress. CMC expects net operating income to be "significantly" higher than the prior year after a strong second half performance. In financial 2017, CMC reported net operating income of GBP160.8 million alongside a pretax profit of GBP48.5 million. "The proportion of high value clients has increased," CMC said in a statement, "driving a significant improvement in revenue per client compared to the prior year. Overall, active client numbers are slightly below the previous year although the final quarter has seen an increase from the prior year."----------OTHER MAIN MARKET AND AIM - LOSERS----------South African Property Opportunities, down 90%. The company said it intends to propose the winding-up of the company shortly after the unsuccessful attempt to sell its Brakpan asset. The firm said it had contracted to sell the Brakpan asset - as part of its strategy to sell its remaining assets - for ZAR11 million, or GBP650,000. However, the company attempted to enforce this contract without success. As South African Property now considers that it is "no longer practicable" to operate in the hope of generating meaningful proceeds from a disposal of the Brakpan Asset, the board will shortly place proposals before shareholders for a voluntary winding-up, the appointment of a liquidator and the cancellation of its shares on AIM.----------
More News
29 Nov 2018 12:50

C4X Discovery Partners With Artificial Intelligence Firm GTN

LONDON (Alliance News) - C4X Discovery Holdings PLC said Thursday that it has entered into a drug discovery partnership with GTN Ltd, a company using artificial intelligence to discover new the to

Read more
29 Nov 2018 12:21

C4X enters drug discovery AI deal with GTN

(Sharecast News) - Drug discovery company C4X Discovery Holdings has entered into a partnership with GTN, a new player in the field of drug discovery artificial intelligence, initially focussing on identifying potential small molecule hits against a high-value neurodegeneration target, it announced on Thursday.

Read more
27 Nov 2018 13:21

C4X Discovery Inks Deal With LifeArc To Develop Small Drug Candidates

LONDON (Alliance News) - C4X Discovery Holdings PLC said Tuesday it has entered into a discovery partnership with LifeArc, a UK medical research charity, to develop small molecule drug candidates

Read more
21 Nov 2018 12:41

C4X Discovery Annual Loss Narrows On Next Generation Programmes

LONDON (Alliance News) - C4X Discovery Holdings PLC on Wednesday said its loss narrowed in its recently ended financial year, as revenue multiplied.The drug discovery company said its loss

Read more
5 Oct 2018 11:01

C4X Discovery Raises GBP10.1 Million From Placing And Open Offer (ALLISS)

LONDON (Alliance News) - C4X Discovery Holdings PLC said Thursday it has received valid acceptances for 99,563 open offer shares from qualifying shareholders.This represents about 9.0% of a

Read more
18 Sep 2018 18:23

UPDATE: C4X Discovery Raises GBP11 Million Via Placing And Open Offer (ALLISS)

LONDON (Alliance News) - C4X Discovery Holdings PLC late Tuesday said it raised GBP10.0 million through placing and a further GBP1.0 million via an open offer.The drug discovery company it

Read more
18 Sep 2018 15:18

C4X Discovery To Raise GBP11 Million Through Placing And Open Offer (ALLISS)

LONDON (Alliance News) - C4X Discovery Holdings PLC on Tuesday said it intends to raise GBP10.0 million through placing and a further GBP1.0 million via an open offer.The drug discovery its

Read more
24 Jul 2018 10:02

C4X Discovery Awarded USD480,000 Grant For Cocaine Addiction Treatment

LONDON (Alliance News) - Drug discovery company C4X Discovery Holdings PLC said on Tuesday it has been awarded a USD480,000 grant from the National Institute on Drug Abuse for the company's US

Read more
4 Jul 2018 11:02

C4X Discovery Appoints Eva-Lotta Allan As Chairman

LONDON (Alliance News) - C4X Discovery Holdings PLC said Wednesday it appointed Eva-Lotta Allan as its new chair and Natalie Walter as non-executive director with immediate effect.Allan is

Read more
1 May 2018 11:41

e-Therapeutics Pens Research Collaboration With C4X Discovery

LONDON (Alliance News) - e-Therapeutics PLC and C4X Discovery Holdings PLC on Tuesday announced a research collaboration to look into insights into Parkinson's disease.The partnership,

Read more
6 Jan 2017 08:13

C4X Discovery Holdings focuses on early licensing deals to drive revenue

(ShareCast News) - Drug discovery company C4X Discovery Holdings is focusing on early licensing deals to drive revenue as it bids to become the world's most productive drug discovery engine. The AIM-listed company said it shifted focus on generating a high value pre-clinical asset portfolio that wil

Read more
30 Dec 2016 12:01

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
22 Nov 2016 10:52

C4X Discovery Makes Interim CFO Permanent, Appoints Two To Board

Read more
6 Sep 2016 08:23

C4X Discovery Attracts New Investors In GBP5 Million Placing (ALLISS)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.